Monopar Therapeutics (NASDAQ:MNPR) showed up in the 13F filings of 81 institutional investors as of March 2026.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| Janus Henderson Group Plc | 31 Mar, 2026 | 2,634,820 | 1,317,410 | 100.00% | $144,124,654.00 |
| RA CAPITAL MANAGEMENT, L.P. | 31 Mar, 2026 | 667,207 | 0 | 0.00% | $36,556,272.00 |
| Saturn V Capital Management LP | 31 Mar, 2026 | 345,626 | 19,925 | 6.12% | $18,936,849.00 |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 31 Mar, 2026 | 323,745 | 153,187 | 89.82% | $17,737,989.00 |
| BlackRock, Inc. | 31 Mar, 2026 | 316,567 | 61,710 | 24.21% | $17,344,705.00 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 31 Mar, 2026 | 309,195 | -330,272 | -51.65% | $16,940,794.00 |
| Siren, L.L.C. | 31 Mar, 2026 | 270,118 | 57,820 | 27.24% | $14,799,765.00 |
| ADAR1 Capital Management, LLC | 31 Mar, 2026 | 264,278 | -203,538 | -43.51% | $14,479,792.00 |
| Polar Capital Holdings Plc | 31 Mar, 2026 | 226,526 | 120,776 | 114.21% | $12,411,360.00 |
| VANGUARD CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 218,463 | 218,463 | 0.00% | $11,969,588.00 |
| WELLINGTON MANAGEMENT GROUP LLP | 31 Mar, 2026 | 174,342 | -51,726 | -22.88% | $9,552,198.00 |
| Sio Capital Management, LLC | 31 Mar, 2026 | 173,506 | 173,506 | 0.00% | $9,506,394.00 |
| BALYASNY ASSET MANAGEMENT L.P. | 31 Mar, 2026 | 136,443 | 104,536 | 327.63% | $7,475,712.00 |
| TCG Crossover Management, LLC | 31 Mar, 2026 | 132,103 | -9,812 | -6.91% | $7,237,923.00 |
| Alyeska Investment Group, L.P. | 31 Mar, 2026 | 100,000 | 60,000 | 150.00% | $5,479,000.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Mar, 2026 | 99,918 | 911 | 0.92% | $5,476,049.00 |
| Vivo Capital, LLC | 31 Mar, 2026 | 90,500 | 0 | 0.00% | $4,958,495.00 |
| State Street Corp | 31 Mar, 2026 | 88,355 | 4,366 | 5.20% | $4,840,970.00 |
| Bank of New York Mellon Corp | 31 Mar, 2026 | 78,618 | 13,761 | 21.22% | $4,307,490.00 |
| Vestal Point Capital, LP | 31 Mar, 2026 | 65,418 | 65,418 | 0.00% | $3,584,252.00 |